A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas.
Michele BasileIlaria ValentiniRoberto AttanasioRenato CozziAgnese PersichettiIrene SamperiAlessandro ScoppolaRenata Simona AuriemmaErnesto De MenisFelice EspositoEmanuele FerranteGiuseppe IatìDiego MazzatentaMaurizio PoggiRoberta RudàFabio TortoraFabio CrucianiZuzana MitrovaRosella SaulleSimona VecchiPaolo CappabiancaAgostino PaolettaAlessandro BozzaoMarco CaputoFrancesco DogliettoFrancesco FerraùAndrea Gerardo LaniaStefano LauretiStefano LelloDavide LocatelliPietro MaffeiGiuseppe MinnitiAlessandro PeriChiara RuiniFabio SettanniAntonio SilvaniNadia VeroneseFranco GrimaldiEnrico PapiniAmerico CicchettiPublished in: Global & regional health technology assessment (2024)
Due to the favorable cost-utility profile and safety of surgical treatment, pituitary surgery should be considered more frequently as the initial therapeutic approach. This management choice could lead to better outcomes and an appropriate allocation of healthcare resources.